Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Too Much of a Good Thing
      • Turning Face Perception on Its Head
      • Safeguarding a Second Chance at Life
      • A Biological Betrayal
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
        • Earl Stadtman Investigator Frequently Asked Questions
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
The NIH Catalyst: A Publication About NIH Intramural Research

National Institutes of Health • Office of the Director | Volume 25 Issue 4 • July–August 2017

Science In Space!

Astronaut Kate Rubins Visits NIH

BY EMILY PETRUS, NINDS

Kate Rubins in her astronaut suit.

PHOTO CREDIT: NASA

NASA astronaut Kate Rubins.

Scientists usually do experiments in controlled environments, with unlimited access to electricity, air, and gravity. Then there are other scientists who find ways to do research in extreme conditions where everything is compact, suspended, and unknown. Kate Rubins, a molecular biologist turned NASA astronaut, knows how to work in controlled as well as extreme environments—from the remote regions of central Africa to the even more remote regions of outer space. On April 25, 2017 (National DNA Day), she visited NIH to talk about her experiences on Expeditions 48 and 49 to the International Space Station (ISS) and participate in a question-and-answer session with NIH Director Francis Collins.

During her 115 days in space (July–October 2016), Rubins performed two space walks and conducted more than 275 experiments. She was the first person to sequence DNA in the microgravity of space.

Rubins has a Ph.D. in cancer biology from Stanford University School of Medicine (Stanford, California), was a fellow and principal investigator at the Whitehead Institute for Biomedical Research (Cambridge, Massachusetts), and has conducted research on poxviruses and host-pathogen interactions as well as viral mechanisms for regulating host-cell messenger-RNA transcription, translation, and decay. Long before she went to the ISS, she had her first experience working in extreme conditions when she and colleagues were studying an outbreak of monkeypox at a remote site in the Democratic Republic of the Congo.

Rubins is now the Deputy Director of Human Health and Performance at NASA’s Johnson Space Center (Houston, Texas), but she is still a flight-eligible astronaut and could go back to space at any time.

During her NIH visit, she showed a video of herself—blonde hair floating wildly—in space doing experiments and even using a cordless power drill as a centrifuge. The science was punctuated with breathtaking images of Earth taken from space (NASA collects the images to study weather patterns). Collins and Rubins then sat on stage for a conversation with questions submitted by NIH employees as well as by online viewers who were participating in a chat on NIH’s Facebook page. The following has been lightly edited for clarity.

COLLINS: One application for being able to sequence DNA in space might be to survey the health of the astronauts. For example, if you could measure RNA expression in peripheral blood cells of somebody who’s not feeling well, we could then say if it’s a viral or bacterial infection. How far along do you think we are with that?

RUBINS: We can draw blood on board, we can make peripheral-blood mononuclear cells (PBMCs), and we can take serum and plasma. So it would be technically feasible to take human-physiology samples, not necessarily just to diagnose disease but to also watch processes like bone loss, fluid changes, and cardiovascular effects. We could look for how the biomarkers of those processes evolve over time.

Kate Rubins in a lab aboard the International Space Station.

PHOTO BY NASA

Better Breathing in Space and Back on Earth: Airway Monitoring, an investigation from ESA (the European Space Agency), uses the U.S. airlock as a hypobaric facility for performing science. Utilizing the U.S. airlock allows unique opportunities for the study of gravity, ambient pressure interactions, and their effect on the human body. This investigation studies the occurrence and indicators of airway inflammation in crew members, using ultra-sensitive gas analyzers to evaluate exhaled air. This could not only help in spaceflight diagnostics, but that also hold applications on earth within diagnostics of similar conditions, for example monitoring of asthma.

COLLINS: What about the health implications of long-term weightlessness such as if we send humans to Mars? What would you want to offer to keep the negative effects from being too severe?

RUBINS: We have a number of things that we think about in terms of risks to astronaut health for long-duration space flight. High among those is the radiation environment. We can protect astronauts from radiation exposure either through shielding of the spacecraft or by giving them a countermeasure such as a radioprotective pill. We also need to work on bone and muscle health, the neurovestibular effects of the microgravity environment, and nutrition. We have the technology to be able to figure out how to keep people safe. So there’s no big showstoppers that are absolutely going to prevent us from going to Mars.

COLLINS: Do you think it’s possible that there are going to be identifiable genetic differences between individuals that are predictive of how well they will do in space? If so, will this play some role in astronaut selection?

RUBINS: Certainly, as precision medicine improves our understanding of human health, we’re going to start using this to understand what would be protective from radiation. We’ve got some early results from studies about nutrition and DNA health and how that might be influencing factors in space flight. I think we’ll continue to look at [individual differences] and try to understand how we can select the best performers in this environment.

COLLINS: How did you end up being an astronaut? You got a Ph.D. in molecular biology, skipped the postdoc, became a Whitehead Fellow, and then ended up in the Space Station. I’ve heard of nonlinear careers but this is ridiculous.

RUBINS: I have NIH to thank for why I became an astronaut. I was writing an R01 [grant application] when my friend called me and said, “There are astronaut applications online.” Applying turned out to be an excellent procrastination tool for my grant writing. I never expected to be selected to be an astronaut.

 Kate Rubins looking at an orange hose aboard the International Space Station.

PHOTO BY NASA

The Sequencing of DNA in Space: When Rubins’ expedition began, DNA had never been sequenced in space. Within just a few weeks, she and the Biomolecule Sequencer team had sequenced their one billionth “base” – the unit of DNA - aboard the orbiting laboratory. The Biomolecule Sequencer investigation seeks to demonstrate that DNA sequencing in microgravity is possible, and adds to the suite of genomics capabilities aboard the space station.

COLLINS: What would it take for students to get engaged in these kinds of scientific adventures? Do you have any advice?

RUBINS: I would encourage them to start experimenting early. There’s reading science in the textbook, and there’s a completely different side of science when you have high schoolers running a gel and they can actually see strands of DNA. [Gel electrophoresis is a technique for separating charged molecules like DNA, according to size.] There are excellent educational materials if you go to NASA.gov and look at the “Education” tab. There are experiments that people can do in their classrooms; there are materials for folks who are interested in learning about space. Having that thrill of discovery, you can use your powers of observation to answer some important questions about the world around you.


You can view Rubins’s April 25 talk, which took place in Masur Auditorium (Building 10), at https://videocast.nih.gov/launch.asp?23239 (NIH and HHS only). In addition, you can read about Rubins’s October 2016 space chat with Francis Collins . Check out Kate Rubins’ Space Station Science Scrapbook, too. Read about how NIH and NASA have collaborated over the years.

This page was last updated on Monday, April 11, 2022

  • Issue Overview
  • Features
    • Middle-Age Weight and Fitness Changes
    • Using 3-D Printing to Assess Radiation Exposure
    • A Conversation with Atul Gawande
    • Science In Space!
    • A Match Made for the Heavens
    • National Week of Making at the NIH Library
  • Departments
    • From the Deputy Director for Intramural Research
    • Alumni News: Bryon Adinoff
    • Colleagues: Recently Tenured
    • Research Briefs
    • News Briefs
    • New Methods
    • The Training Page
    • From the Annals of NIH History
    • Announcements
  • Issue Contents
  • Download this issue as a PDF

Catalyst menu

  • Current Issue
  • Previous Issues
  • About The NIH Catalyst
  • Contact The NIH Catalyst
  • Share Your Story
  • NIH Abbreviations

Catalyst links

  • Follow The NIH Catalyst

Subscribe Today!

Subscribe to The NIH Catalyst Newsletter and receive email updates.

Subscribe

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search